Synthesis and anti-mycobacterial activity of of (E)-N-(monosubstituted-benzylidene)isonicotinohydrazide derivatives

Authors: Lourenço, M.C.; Ferreira, M.L.; De Souza, M.V.N.; Peralta, M.A.; Vasconcelos. T.A.; Henriques, M.G.M.O.


Abstract

A series of 22 (E)-N′-(monosubstituted-benzylidene)isonicotinohydrazide derivatives have been synthesized and evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv using Alamar Blue susceptibility test and the activity expressed as the minimum inhibitory concentration (MIC) in μg/mL. Compounds 2f, 2g, 2j, 2k and 2q exhibited a significant activity (0.31–0.62 μg/mL) when compared with first line drugs such as isoniazid (INH) and rifampicin (RIP) and could be a good starting point to develop new lead compounds in the fight against multi-drug resistant tuberculosis.
Keywords:Isoniazid; Mycobacterium tuberculosisDerivatives;Anti-mycobacterial Document Type: Research Article DOI: http://dx.doi.org/10.1016/j.ejmech.2007.08.003 Publication date: 1 de Junho de 2008

Compartilhar publicação

Facebook
Twitter
Email
LinkedIn
WhatsApp

Deixe seu comentário

Compartilhar

Sobre a SSCDT

Nosso grupo de pesquisa está situado em Farmanguinhos e atualmente é o maior laboratório farmacêutico oficial vinculado ao Ministério da Saúde. Farmanguinhos produz mais de um bilhão de medicamentos por ano para os programas estratégicos do Governo Federal, além de atender demandas emergenciais no Brasil e no exterior.

posts Recentes